Cutter & CO Brokerage, Inc. - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 75 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 27.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutter & CO Brokerage, Inc. ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q4 2022$9,638
-54.1%
13,575
-1.5%
0.00%
-62.5%
Q3 2022$21,000
+61.5%
13,775
+4.6%
0.01%
+100.0%
Q2 2022$13,000
-31.6%
13,1750.0%0.00%
-33.3%
Q1 2022$19,000
-73.2%
13,175
-2.9%
0.01%
-68.4%
Q4 2021$71,000
-18.4%
13,575
-8.7%
0.02%
-9.5%
Q3 2021$87,000
-27.5%
14,8750.0%0.02%
-25.0%
Q2 2021$120,000
-7.0%
14,875
-3.9%
0.03%
-9.7%
Q1 2021$129,000
+16.2%
15,475
+5.2%
0.03%
+6.9%
Q4 2020$111,000
-59.3%
14,705
-42.6%
0.03%
-64.2%
Q3 2020$273,000
-27.4%
25,625
+3.3%
0.08%
-33.6%
Q2 2020$376,000
+174.5%
24,795
+50.6%
0.12%
+134.6%
Q1 2020$137,000
-60.3%
16,465
-19.4%
0.05%
-57.0%
Q4 2019$345,000
-10.9%
20,439
-1.9%
0.12%
-2.4%
Q3 2019$387,000
-18.9%
20,8450.0%0.12%
-17.9%
Q2 2019$477,000
+6.7%
20,845
-1.9%
0.15%
+18.9%
Q1 2019$447,000
+83.2%
21,2450.0%0.13%
+36.6%
Q4 2018$244,000
-59.1%
21,245
-18.3%
0.09%
-54.4%
Q3 2018$597,000
+0.8%
25,995
-2.1%
0.20%
-10.5%
Q2 2018$592,000
-3.3%
26,545
-0.9%
0.23%
-5.8%
Q1 2018$612,000
-12.3%
26,785
+0.6%
0.24%
-15.7%
Q4 2017$698,000
+16.1%
26,635
-0.6%
0.29%
+20.6%
Q3 2017$601,000
-18.6%
26,785
-0.7%
0.24%
-17.9%
Q2 2017$738,000
+13.0%
26,9850.0%0.29%
+7.4%
Q1 2017$653,000
+12.8%
26,985
-3.2%
0.27%
+12.5%
Q4 2016$579,000
-22.3%
27,885
+2.0%
0.24%
-26.2%
Q3 2016$745,000
+96.1%
27,335
+3.4%
0.32%
+100.6%
Q2 2016$380,000
+2.2%
26,435
+2.1%
0.16%
-5.8%
Q1 2016$372,000
-15.3%
25,885
+26.7%
0.17%
-16.1%
Q4 2015$439,000
+32.6%
20,4350.0%0.20%
+25.8%
Q3 2015$331,000
-13.8%
20,435
+37.5%
0.16%
+6.5%
Q2 2015$384,000
+37.6%
14,860
+19.7%
0.15%
+34.2%
Q1 2015$279,000
+27.4%
12,410
+9.0%
0.11%
+37.3%
Q4 2014$219,00011,3900.08%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders